DHFB
BSX icon

Dixon Hubard Feinour & Brown’s Boston Scientific BSX Stock Holding History

Dixon Hubard Feinour & Brown’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$742K Sell
19,920
-13,190
-40% -$537K 0.09% 169
2022
Q1 		$1.47M Sell
33,110
-2,550
-7% -$111K 0.15% 138
2021
Q4 		$1.51M Buy
+35,660
New +$1.5M 0.15% 135

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Dixon Hubard Feinour & Brown's BSX Position: Q2 2022 in Review

Dixon Hubard Feinour & Brown reduced its Boston Scientific (BSX) stake by 40% in Q2 2022, selling an estimated $537K and leaving 19,920 shares worth $742K. The position accounts for 0.09% of the portfolio, ranked #169.

Dixon Hubard Feinour & Brown first reported a position in BSX in Q4 2021 and has held it in 3 quarters since. The position peaked at $1.51M in Q4 2021. 878 funds tracked by Wall St. Rank hold BSX as of Q2 2022.

  • Dixon Hubard Feinour & Brown held 19,920 shares of Boston Scientific worth $742K as of Q2 2022.
  • Dixon Hubard Feinour & Brown sold 13,190 Boston Scientific shares in Q2 2022, an estimated $537K.
  • Boston Scientific made up 0.09% of Dixon Hubard Feinour & Brown's portfolio in Q2 2022, its #169 holding.
  • Dixon Hubard Feinour & Brown first reported a position in Boston Scientific in Q4 2021 and has held it in 3 quarters since.
  • Dixon Hubard Feinour & Brown's Boston Scientific position peaked at $1.51M in Q4 2021.
  • 878 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2022.

Based on Dixon Hubard Feinour & Brown's 13F filing for Q2 2022, filed 22 Jul 2022.